Genitourinary Cancers

Latest News

The FDA has approved Zynyz as a first-line treatment in advanced anal cancer.
FDA Approves Zynyz Treatment Regimen for Advanced Anal Cancer

May 15th 2025

The FDA has approved Zynyz as a first-line treatment in combination with chemo and as a single-agent following progression in advanced anal cancer.

There were a number of notable developments for patients with kidney cancer at the symposium: © SciePro - stock.adobe.com
What Patients With Kidney Cancer Need to Know From ASCO GU

March 30th 2025

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium; © Cavan - stock.adobe.com
Biomarkers, Genetic Testing and More Make Way in GU Cancers

March 5th 2025

Dr. Chandler Park helps patients with genitourinary cancer understand the importance of genetic testing: © lucky - stock.adobe.com
There is a Growing Need For Genetic Testing and Precision Medicine in GU Cancers

February 28th 2025

Image of man holding stomach.
GAP Regimen May Not Improve Survival in Biliary Tract Cancer Subset

February 17th 2025

More News